Browsed by
Tag: stockscreening

Quick Screening Series: SIA Engineering(S59.SI)

Quick Screening Series: SIA Engineering(S59.SI)



This column is written by @calvinwee
-Calvin is a fundamental analyst at heart and an ardent disciple of value investing. He relishes the process of searching for undervalued stocks and enjoys collecting dividends from his stocks.
Company overview:
SIA Engineering Company Ltd (SIAE) specialises in providing aircraft maintenance, repair, and overhaul (MRO) services. SIAE is a subsidiary of Singapore Airlines Ltd (SGX: C6L), counts over 80 international airlines as its customers.SIAE is split into the following 2 segments:

 

1. Repair & Overhaul
SIAE offers a one-stop service for virtually all types of airplane issues, ranging from airframe maintenance to component overhaul. SIAE’s primary edge lies in its Joint Ventures and its strategic partnership with Pratt and Whitney and Rolls-Royce and most recently in June, GE Aviation, the top aircraft engine manufacturers in the world. This bestow it with the capabilities to repair major aircraft engines.

 

2. Line Maintenance
Apart from its operations of checking each plane before the flight in Changi Airport, SIAE have business interests in Hong Kong, Indonesia, Philippines, Australia, USA and Vietnam through its JVs.

Read More Read More

Longer Screening Series: Silverlake Axis(5CP.SI)

Longer Screening Series: Silverlake Axis(5CP.SI)



This column written by @J_Chou
-Jay has an interest in global macro trends, financial markets and equity research and enjoys applying a combination of the three in his investments. His eventual investing goal is to manage a risk parity portfolio and achieve true financial freedom.

Disclaimer: I am vested in this stock.

Introduction
Silverlake is Asia’s leading software services and solutions provider. The company provides digital economy solutions and services to the banking, insurance, payment, retail, and logistics industries. The company also offers software project implementation services to deliver end-to-end banking, payment, and retail solutions; maintenance and enhancement services; outsourcing services for the processing of credit and debit cards, and other credit products; and cloud computing Software as a Service platform for policy origination and claim processing for the insurance industry, as well as sells software and hardware products. It operates in South East Asia, North East Asia, South Asia, the Middle East, North America, Africa and Europe. Its major customers include 40% of the largest banks in South East Asia such as OCBC, UOB, Maybank, CIMB Group.

Read More Read More

Upcoming SingMedical EGM: 5 July.  Know more about SingMedical(5OT.SI)’s acquisition of Cancer Centre Pte Ltd before the EGM!

Upcoming SingMedical EGM: 5 July.  Know more about SingMedical(5OT.SI)’s acquisition of Cancer Centre Pte Ltd before the EGM!


-Gordon has a demonstrable interest in equity investments, financial markets, and negotiating deals. As @NTUInvestmentClub president, he has an understanding of what factors drive an organisation’s success.

About Singapore Medical Group Ltd (SMG)
Singapore Medical Group Ltd (SMG) operates medical clinics and provides medical services. The group operates through 3 segments: health, aesthetics and diagnostics.

About Cancer Centre Pte Ltd
Cancer Centre is a company incorporated in Singapore on 26 December 2007 with its principal activity being the provision of screening and treatment of general cancer services. They operate at Paragon and Mouth Elizabeth Novena. SMG is already an 80% stakeholder of Cancer Centre, with Dr Wong Seng Weng (founder and director of Cancer Centre) holding the other 20%.

Read More Read More

Upcoming Tianjin ZX USD(T14.SI) EGM: 30 June. Know More About Tianjin ZX’s business before the EGM!

Upcoming Tianjin ZX USD(T14.SI) EGM: 30 June. Know More About Tianjin ZX’s business before the EGM!



This column is written by @fayewang
-Faye is both a fundamental analyst and economist by nature. She is a global thinker who’s open-minded and enjoys learning from the market.

Upcoming Event:
28 June, 2017 EX-dividend date
30 June, 2017 Extraordinary general meeting at 1:30 pm, Pinnacle Suite, Wangz Business Centre, 7 Temasek Blvd, #44-01, The Penthouse Suntec Tower 1, Singapore 038987

Brief Background:
Tianjin Zhongxin Pharmaceutical Group Corporation Limited (天津中新药业) is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. Tianjin Zhongxin is a core business part of Tianjin Pharmaceutical Group Corporation Limited (天津医药集团) as the company contributed 53% of the group revenue.
The company operates in three segments:
1)Chinese Medicine
2)Western Medicine
3)Others

Read More Read More

Quick Screening Series – ISOTeam(5WF.SI)

Quick Screening Series – ISOTeam(5WF.SI)



This column is written by @gordon_ong.
-Gordon has a demonstrable interest in equity investments, financial markets, and negotiating deals. As @NTUInvestmentClub president, he has an understanding of what factors drive an organisation’s success.

ISOTeam conducts building maintenance and estate upgrading. It has 4 segments: Repairs and Redecoration (R&R), Addition and Alteration (A&A), Coating and Painting (C&P), and Others such as interior designing, home retrofitting, renewables etc.

Read More Read More

Quick Screening – Pan United (P52.SI)

Quick Screening – Pan United (P52.SI)

Starting a series where I will screen for possible investment opportunities before delving deeper into the numbers. The analysis will be primarily qualitatively focused.



This column is written by @gordon_ong.
-Gordon has a demonstrable interest in equity investments, financial markets, and negotiating deals. As @NTUInvestmentClub president, he has an understanding of what factors drive an organisation’s success.

Macro
+ BCA forecasted that public-sector spending will increase during 2016-2020. Due to the time lag between securing contracts and beginning construction, there is a delayed effect on demand for RMC and cement. Hence, there is still hope for a pickup of RMC and cement prices.

Read More Read More